Status:
COMPLETED
Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Kidney Transplantation
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.
Eligibility Criteria
Inclusion
- Male and Female
- Between 18 to 65 years old
Exclusion
- Patients in need of multiple organ transplants
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
255 Patients enrolled
Trial Details
Trial ID
NCT00099749
Start Date
November 1 2003
Last Update
February 23 2017
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Loyola University Medical Center
Maywood, Illinois, United States, 60153
2
SIU School of Medicine
Springfield, Illinois, United States, 62781
3
St. Barnabas Medical Center
Livingston, New Jersey, United States, 07039
4
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104